Glioblastoma multiform (GBM), the most common and aggressive primary brain tumor, is characterized by a high degree of hypoxia and resistance to therapy because of its adaptation capacities, including autophagy and growth factors signaling. In this study, we show an efficient hypoxia-induced survival autophagy in four different GBM cell lines (U87MG, M059K, M059J and LN-18) and an activation of a particular neurotrophin signaling pathway. Indeed, the enhancement of both TrkC and NT-3 was followed by downstream p38MAPK phosphorylation, suggesting the occurrence of a survival autocrine loop. Autophagy inhibition increased the hypoxia-induced expression of TrkC and its phosphorylated form as well as the phosphorylation of p38, suggesting a complementary effect of the two processes, leading to cell survival. Alone, autophagy inhibition reduced cellular growth without inducing cell death. However, the double inhibition of autophagy and TrkC signaling was necessary to bring cells to death as shown by PARP cleavage, particularly important in hypoxia. Moreover, a very high expression of TrkC and NT-3 was found in tumor sections from GBM patients, highlighting the importance of neurotrophic signaling in GBM tumor cell survival. These data suggest that a combined treatment targeting these two pathways could be considered in order to induce the death of GBM cells.
Introduction
Glioblastoma (GBM) is a malignant astrocytic tumor, classified as grade IV, according to the World Health Organization (WHO) classification (1) , which has recently been updated (2) . Indeed, it is the most common and the most aggressive brain tumor (1) occurring at any age (3), even if it is more frequent between ages 45 and 70 (4) . Primary GBM are characterized by an amplification of EGFR (Endothelial Growth Factor Receptor) in 36% of cases and TP53 mutations in 30% (5), whereas secondary GBM are characterized by a high incidence of TP53 mutations (65%) and, less frequently, by an amplification of EGFR (8%). GBM consists of two histological distinct tumor areas: (i) A very high cell density area associated with atypical nuclei and a high mitotic index and (ii) An area in which isolated cancer cells invade the parenchyma which remains morphologically and functionally intact (6) . GBM is characterized by a high degree of hypoxia, due in part to anarchic cell growth, oxygen consumption and aberrant neovasculature (7) . Tumor cells adapt to oxygen deprivation by triggering signaling pathways, enabling the tumor to withstand not only hypoxia (8) , but also treatments (9, 10) . The capacity to bring the cells to a particularly high degree of resistance to apoptosis contributes to tumor aggressiveness and therapy escape. It is currently accepted that up-regulation of autophagy during hypoxia can favor tumor cell survival and growth (11, 12) .
Autophagy, a conserved catabolic process (13) implies engulfment of organelles and macromolecules into double-membrane vesicles termed autophagosomes, which merge with lysosomes to form the autophagolysosome (14) . Autophagosome content is dismantled by lysosomal enzymes and further recycled into cellular anabolism (15) . Autophagic process involves several specific genes named ATG (AuTophaGy related) (13) : Atg6 protein (Beclin1 in mammals) participates in autophagosome initiation, Atg5 in elongation and Atg8 (Microtubule-Associated Protein Light Chain 3 named LC3 in mammals) in the achievement of autophagosome formation (13) . During this process, the LC3I protein, the free cytosolic form of LC3, is converted into the phosphatidylethanolamine-linked autophagosomal form LC3II (16) . LC3 is the most widely used autophagic marker (17) . Another important event is the degradation of the p62 protein, which allows the recognition of ubiquitinated aggregates by the autophagosome (18) . It has been demonstrated that, in basal conditions, the low rate of autophagy, which is important for maintaining homeostasis, could be greatly enhanced under stress including hypoxia (12, 19, 20) . Indeed, the hypoxia-inducible factor HIF1 induces BNIP3 expression (BcL-2/Adenovirus E1B-19K-interacting protein 3), which in turn increases autophagy through activation of Beclin1 (20, 21) .
In addition to enhanced autophagy, growth factors often show abnormal expression in human glioblastoma (22) . Neurotrophins (NTs), which play an important role in the nervous system, belong to this growth factor family. They are involved in the differentiation, proliferation, survival, apoptosis as well as axonal growth and synaptic plasticity of neuronal cells and astrocytes (23) . Furthermore, NTs exhibit an overexpression in several cancers and could be associated with either poor (24) or good (25) , especially by induction of autophagic cell death. NT family is primarily composed of three members: the nerve growth factor (NGF) (26) , the brain-derived neurotrophic factor (BDNF) (27) and neurotrophin-3 (NT-3) (28), which bind the tropomyosin-related kinase (Trk) receptors TrkA, TrkB and TrkC, respectively (29) . After binding NT, three major intracellular signaling pathways can be activated, i.e. the PI3K/Akt (phosphatidylinositide 3 kinase/Akt) pathway, the MAPK (mitogenic activated protein kinase) pathway, and/or the PLC-γ (phospholipase C gamma 1) pathway, promoting primarily cell survival and differentiation (29) . Whereas the dysregulation of NT signaling, especially TrkB/BDNF (30) , is shown to be associated with tumorigenesis, little is known about TrkC implication in GBM.
Herein, we show that, under hypoxic stress, human GBM cells induce efficient survival autophagy and increase TrkC expression, along with p38MAPK activation. Inhibition of this MAPK induces a discrete PARP cleavage, which is further enhanced upon inhibition of autophagy, suggesting a new possible therapeutic field.
Materials and methods

Cell culture and transfection
U87MG, the most frequently studied GBM cell line, M059K, M059J and LN-18 GBM cells were obtained from American Type Culture Collection. All cell lines were authenticated and characterized by the supplier and we checked EGFR and TP53 status by FISH and MLPA (Multiplex ligationdependent probe amplification) technics, respectively. The four cell lines exhibited different gene amplifications and mutations (lack of amplified EGFR in U87MG, M059K and M059J and amplified EGFR in LN-18, mutation in exon 8 of TP53 in M059J, M059K and LN-18 and TP53 wild type in U87MG, data not shown). After immediate expanding, multiple aliquots were cryopreserved and cells were used within 6 months after thawing, not exceeding 10 passages. Cells were cultured either in Dulbecco's Modified Eagle's Medium (DMEM; U87MG cell line) or in DMEM / F12 (M059K cell line; Gibco Life Technologies, Saint-Aubin, France). Both media contained GlutaMAXTM and were supplied with 10% Fetal Bovine Serum (Lonza, Verviers, Belgium), 1% Non-Essential Amino Acids and 1% Penicillin/ Streptomycin (Gibco Life Technologies), under normoxia (5% CO 2 , 20% O 2 ) or hypoxia (5% CO 2 , 1% O 2 ) in a humidified incubator (Binder, Gennevilliers, France) never opened during incubation. Incubation was done for 4, 8, 12, 16 and 24 hours with or without 40 µM of chloroquine (CQ, Gibco Life Technologies), an inhibitor of lysosomal activity.
GBM cells lines were infected with virions produced in HEK cells after transfection with either pCT-Autophago-GFP (System Biosciences, Ozyme, Saint-Quentin-en-Yvelines, France) or its counterpart without LC3 DNA sequence, pLKO or shRNA TrkC (Clones TRCN 194821, TRCN 2313 and TRCN 2309 from Sigma-Aldrich, Saint-Quentin-Fallavier, France), using jetPEI (Polyplus, Strasbourg, France). Transfected cells were selected with puromycin (1 µg/mL, Sigma-Aldrich). Furthermore, cells with high copies of GFP-LC3 vector were separated by cell sorting (FACSAria SORP 5 colors, Becton Dickinson, Le Pont-de-Claix, France).
For siRNA transfection, cells were transfected using INTERFERIN Transfection Reagent (Polyplus, Ozyme) with 20 nmol/L of negative control, Beclin1, Atg5 or p38MAPK siRNAs (Cell Signaling Technology, Ozyme). After 48 h, knockdown was confirmed by western blotting.
Primary and secondary antibodies
Primary antibodies used for western blotting were to PARP, Beclin1, Atg5, p62, LC3, p38, phospho-p38, Akt, phospho-Akt, mTOR, phospho-mTOR (1/1000, Cell Signaling Technology), TrkC (1μg/mL, R&D, Lille, France), ERK1/2, phospho-ERK1/2 (0.1 µg/mL, R&D Biosystem), phospho-TrkC (1/500 Abcam, Paris, France), α-tubulin (1/200 Santa Cruz Biothechnology, CliniSciences, Nanterre, France). Primary antibodies used for indirect immunofluorescence were to GFP (1/200, Cell Signaling Technology), and TrkC (2.5 μg/mL, R&D). Primary antibodies for immunohistochemistry were used as follows: LC3 (1/200, Nanotools, Tenïngen, Germany), BNIP3 (1/50, ThermoFisher Scientific, Villebon-sur-Yvette, France), TrkC (1/50, Novus Biologicals), Ki67 (1/100, Dako, Les Ulis, France) and NT-3 (1/50, R&D). Secondary antibodies were from Dako for western blot and from Molecular Probes for immunofluorescence.
Cytotoxicity XTT assay
The cytotoxic effect of hypoxia, CQ and different siRNAs was determined using XTT assay (2,3-bis[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide; Cell Proliferation Kit II from Roche diagnostics, Meylan, France). XTT formazan production is proportional to mitochondrial succinate dehydrogenase activity and indirectly reflects cell viability. The test was performed according to the manufacturer's instructions on 8000 cells/well. Absorbance (A) at 490 nm (in reference to 690 nm) was determined in a Multiskan FC (Thermo Scientific) absorbance reader. Hypoxia cytotoxicity was evaluated by the ratio of A developed by hypoxic cells to A developed by normoxic ones; siRNAs cytotoxicity was evaluated by the ratio of A from cells transfected with a specific siRNA to A from cells transfected with a control one.
Western blotting and semi-quantification
Cells cultured in normoxia or hypoxia were collected at each incubation time. They were lysed for 5 min at 4°C in Cell Lysis Buffer (Cell Signaling) added with 1 mM PMSF, proteases and phosphatases inhibitors (Sigma Aldrich). Cells were then disrupted by sonication and centrifuged at 14 000g for 20 min at 4°C. After protein concentration determination (Bradford protein assay, Sigma Aldrich), 30 
Indirect immunofluorescence
Cells were grown in Lab-Teck chamber slides (0.8 cm 2 , Thermo Scientific Nunc) in supplemented DMEM under normoxia or hypoxia conditions for different times. After washing once in PBS at 4°C, cells were fixed and permeabilized in cold methanol for 5 min at RT. After the blocking step in 3% PBS-BSA, cells were incubated with monoclonal primary antibody diluted (1/200) in blocking solution overnight at 4°C under gentle agitation, followed by incubation with the appropriate Alexa™-labeled (Invitrogen, Cergy-Pontoise, France) secondary antibody (1/500) for 2 h at room temperature (RT) in the dark; nuclei counterstaining with DAPI (1 µg/mL, ThermoFisher Scientific) was finally performed for 15 min at RT. Slides were mounted with special fluorescent mounting medium (Dako) before analysis under epifluorescence (Eclipse E800, Nikon, Champigny sur Marne, France) or confocal microscopy (LSM 510 META, Zeiss, Göttingen, Germany). Relative quantification of green fluorescence was assessed by surface plot analysis using ImageJ software program (NIH).
Quantitative RT-PCR
After culture in normoxia or hypoxia, cells were collected at each incubation time. RNA extraction was performed using RNeasy® Mini Kit (Qiagen, Courtaboeuf) and reverse-transcribed using the High Capacity cDNA Reverse Transcription kit (Applied Biosystem). PCR reactions were conducted in triplicate with TaqMan® Fast Universal PCR Master Mix (Applied Biosystem ThermoFisher Scientific) using 100 ng cDNA per reaction. Samples were pre-incubated at 95°C for 12 s and then subjected to amplification over 40 cycles consisting of a 2 s melting step (94°C) and a 20 s extension step (60°C). Amplification was measured using a StepOnePlus TM Real-Time PCR System (Applied Biosystem). Primers and probes (Life technologies) used are shown in Supplementary Table 1. All Ct (Cycle Threshold) obtained were normalized to HPRT1 transcripts and then transcripts relative quantities (RQ) in hypoxic samples versus normoxia were calculated.
Tumor samples from patients, processing and staining
Paraffin-embedded human tumors sections of 5 cavernoma and 20 glioblastoma have been provided by the "Service d'Anatomo-Pathologie" of the Limoges CHU. After antigen retrieval treatment, endogenous peroxidase quenching and non-specific blocking, sections were stained with primary antibody for 2 h RT (LC3, Ki67) or overnight at 4°C (BNIP3, TrkC and NT-3). Subsequently, Dako EnVision kit was used for revelation. A counterstaining was done with hematoxylin (Merck Millipore, Darmstadt, Germany) and lithium carbonate. Immunohistochemistry staining density was determined using ImageJ (NIH).
Statistics
All experiments were done independently at least three times. Data were statistically analyzed by ANOVA test with STATVIEW 5.0 (Abaccus).
Results
Hypoxia activates a functional autophagy in GBM cells
The overall study was realized with four different GBM cell lines, U87MG, M059K, M059J and LN-18 cultured up to 16 h in hypoxic conditions (1% O 2 ), comparatively to normoxia. The hypoxic condition was checked by detection of the translocation of HIF-1 into the nucleus and the subsequent up-regulation of BNIP3 expression, a well-known target of HIF-1. As expected, HIF-1 was translocated into the nucleus as early as after 2 h of hypoxia (data not shown), ahead of BNIP3 expression enhancement, which happened after 4 h of hypoxia, and remained at a high level overall the stress period ( Figure 1A , left panels and Supplementary Figure 1A) . It has been previously reported that such low oxygen environment induced autophagy in GBM cells (7) and we monitored LC3II conversion (a classical autophagic marker) along the incubation. Cells constitutively exhibited an important basal level of autophagy in normoxia, already reported as a hallmark of GBM cells (31) . The process significantly increased with hypoxia: for example in U87MG, the LC3II band displayed a relative intensity of 1.43 after 16 h in hypoxia versus 1 in normoxia, P < 0.001 ( Figure 1A , left panels); similar results were observed with the three other GBM cell lines (Supplementary Figure 1A) . Stress-induced autophagy was also evidenced by changes in p62 degradation ( Figure 1A , left panels and Supplementary Figure 1A) , which was significantly reduced in U87MG cells at 16 h hypoxia comparatively to normoxia (0.55 versus 1 respectively, P < 0.001); this event serves as an index of autophagic degradation (32) . In order to check the autophagic flux, the same analyses were achieved in the presence of chloroquine (CQ), an autophagic inhibitor known to inhibit lysosomal acidification and fusion with autophagosome (33) . As CQ inhibits autophagy after LC3II formation, it also caused a significant increase of this form ( Figure 1A , right panels and Supplementary Figure 1B ). Yet, we observed a hypoxia-induced p62 accumulation enhancement, higher in U87MG cell line ( Figure 1A , right panels and Supplementary Figure 1B) . In these cells, the event appeared significantly as early as after 4 h of hypoxia (2.39 versus 1 in normoxic conditions, P < 0.001) and this level was maintained all along the experiment (2.38 at 16 h hypoxia versus 1 in normoxic conditions, P < 0.001).
These results were confirmed by the punctate localization of LC3 to autophagosomes in GFP-LC3-transfected cells, whose intensities were largely enhanced by hypoxia in the four studied cell lines. Surface plot analysis of cytoplasmic green fluorescence as well as evaluation of the numbers of GFP-LC3 puncta per cell and of GFP-LC3-punctate-containing cells highlighted this increase in U87MG cells ( Figure 1B) . Similar results were observed with the three other GBM cell lines (Supplementary Figure 1C) . Study of GFP-LC3-transfected cells where inhibition of autophagy was performed with CQ, also exhibited amplifying punctate localization of LC3 to autophagosomes ( Figure 1B and Supplementary Figure 1D ). These data confirm the occurrence of a functional autophagic process in response to hypoxia in the four GBM cell lines.
We then analyzed the impact of hypoxia-induced autophagy inhibition on GBM cell fate, presuming that this process greatly contributes to cell survival. Thus, viable cell number was evaluated in normoxia and hypoxia in the presence, or not, of CQ, and the obtained values were normalized to hypoxia ( Figure 1C and Supplementary Figure 1E ). Hypoxic stress significantly slowed down cellular proliferation either in the presence or absence of CQ at 4 and 8 h in the four studied cell lines. Proliferation rose after 12 h to approach normal values by 24 h while autophagy was actually working, supporting the conclusion that this process helped cell survival in hostile conditions. However, even if CQ-treated cells were unable to resume normal growth, the proliferation rate never fell below 80%, even after 48 h ( Figure 1C and Supplementary Figure 1E) , suggesting that an additional protective process did occur in hypoxic conditions.
Hypoxia and autophagy inhibition increase expression and activation of TrkC
It is well known that human glioma cells exhibit abnormalities in relation with their sensitivity to growth factor pathway.
Since the neurotrophin family is particularly implied in the nervous system (24), we focused our analyses on the expression of these growth factors and their receptors, including high and low affinity receptors (more precisely TrkA, TrkB, TrkC and 
p75 NTR
). NT-3 was the only neurotrophin whose transcriptional expression was strongly enhanced in hypoxia comparatively to normoxia in U87MG cells (Figure 2A , P < 0.001 for the three exposition times), whereas changes failed to appear in M059K and were weaker in M059J and LN-18 (Supplementary Figure 2) . This increase was not accompanied by an enhancement of the NT-3 protein band ( Figure 2B ). This discrepancy could be explained by the fact that western blot analyses were done with cell lysates while neurotrophins, indeed, are actually secreted molecules. In accordance with these data, TrkC, the NT-3 specific receptor, was also the only member of this receptor family to be enhanced by hypoxia in the U87MG cell line (Figure 2A) , confirmed with the three other cell lines (Supplementary Figure 2) . It is noteworthy that TrkC levels (both transcript and protein) were significantly higher compared to normoxia (Figure 2A and B, P < 0.001). Furthermore, the fact that phospho-TrkC was also increased, especially at 12 and 16 h of hypoxia ( Figure 2B ) suggested the involvement of a survival autocrine loop implying TrkC/NT-3 signaling in U87MG cells. Thus, hypoxic stress seems to boost two survival processes, autophagy and TrkC/NT-3.
Since we hypothesized a synergistic effect of the two survival pathways, we checked the possible impact of autophagy inhibition on TrkC expression in U87MG cells, in which this receptor was the most prominent. Expression and phosphorylation of TrkC were increased following CQ treatment, and these increases were further enhanced when cells were cultured under hypoxia (2.3 at 16 h hypoxia versus 1 in normoxic conditions, P < 0.001, Figure 2C ). Similar results were obtained when autophagy was inhibited by siRNA transfection (whose validation was checked by western blotting, Supplementary Figure 3A ) against Beclin1 and Atg5 transcripts ( Figure 2D ). These results ensure that the TrkC enhancement was a consequence of autophagy inhibition and not to a possible side effect of CQ. Immunofluorescence results of GFP-LC3-transfected U87MG cells failed to show any co-localization between TrkC and autophagosomes ( Figure 2E ). This result contradicted the assumption of TrkC degradation by autophagy and supported a role of TrkC in offsetting the lack of autophagy, instead. The enhancement of both total and phosphorylated TrkC forms suggested that the receptor is actually functional.
Hypoxia and autophagy inhibition increase the p38MAPK activation as a downstream target of TrkC signaling
Phosphorylated TrkC could engage in a downstream signaling and we found that this was the case in hypoxic conditions ( Figure 2B) . Classically, the PI3K/Akt/mTOR and the MAP kinases pathways could be downstream activated (29) . We evaluated by western blot the expression of the major proteins involved in these signaling pathways ( Figure 3A) . Statistical analyses showed that phospho-Erk1/2 levels decreased slowly, whereas phospho-p38MAPK level increased with hypoxia since 4 h, suggesting that this kinase could mediate cell survival in response to the environmental stress. As in the case with TrkC and phospho-TrkC, we checked p38 activation as a consequence of autophagy inhibition. We found that CQ upregulated the phosphorylated form of p38, and more especially in hypoxia, underscoring the commitment of TrkC signaling ( Figure 3B ). However, since p38MAPK could respond to a variety of upstream signaling regulators, we checked the phosphorylation status of p38MAPK, when TrkC was inhibited by shRNA. After confirmation of TrkC inhibition by Q-RT-PCR (Supplementary Figure 3B) , the reversal of p38MAPK was evidenced, especially in hypoxia as shown in Figure 3C . These results emphasize the TrkC compensation role involving p38 pathway, in response to hypoxia, when autophagy is inhibited.
Neurotrophin and autophagy twin inhibition is required to trigger cell death
We have already shown that, in hypoxia, the slowing down of cellular proliferation is only transient and is followed by growth resuming whereas CQ-induced autophagy inhibition avoided this recovery ( Figure 1C and Supplementary Figure 1E) . In order to complete this study, we assessed the cellular metabolic activity after autophagy inhibition, by using CQ or transfection with siBeclin1 or siAtg5, in hypoxic conditions compared to normoxia in U87MG cell line. Both CQ treatment and autophagyspecific siRNA induced a significant time-dependent decrease of the metabolic process in hypoxia-cultured cells, as observed in Figure 4A . The loss reached almost 30% with CQ inhibition, 20% and 40% with Beclin1 and Atg5 siRNA respectively, at 16 h of hypoxia. Similar results were obtained with the three other cell lines when using CQ (Supplementary Figure 4A) and in M059K cells when using siRNA (Supplementary Figure 4B and C) . The cell viability, assessed by trypan blue exclusion, decreased to 80% ( Figure 1C) . In order to link this observation to the apoptotic pathway activation, we analyzed PARP cleavage during the stress in the presence of autophagy inhibitors. Neither CQ nor siRNA induced such event in the treated hypoxic U87MG cells ( Figure 4B , respectively left and right panels). Similar results were obtained with the 3 others cell lines used (Supplementary Figure 4D and E) . Thus, inhibition of the hypoxia-induced autophagy failed to cause cell death in the four tested cell lines, thus reinforcing the role of TrkC as additional survival pathway of GBM cell lines in response to hypoxia. To check this assumption, we inhibited p38MAPK, whose phosphorylation increased in hypoxic U87MG cell line, by using specific siRNA (of which we ensured efficiency, Supplementary Figure 3C) . Following p38 impairment, the cellular metabolic activity was unchanged in cells cultured in normoxia whereas it significantly decreased after 16 h in hypoxic condition ( Figure 4C , left panel, P < 0.001). Co-inhibition of p38 and autophagy in the presence of CQ further affected the mitochondrial activity, thereby increasing the cellular cytotoxicity in normoxia as well as hypoxia ( Figure 4C , left panel, 0.31 and 0.24 respectively versus 1). These events were accompanied by a decrease of viable cells ( Figure 4C , right panel), which fell to almost 40% after double inhibition comparatively to the control (P < 0.001). In order to link this cytotoxicity and proliferation reduction to apoptotic cell death, we evaluated PARP truncation in the same conditions ( Figure 4D ). With sip-38MAPK, we observed a slight PARP cleavage in hypoxic condition, which was further enhanced upon CQ treatment. Moreover, twin inhibition of TrkC and autophagy decreased significantly colonies formation and size in U87-MG cell line (Supplementary Figure 5) , suggesting the relevance of both pathways to support aggressiveness of GBM cells. These data underline the importance of both autophagic and neurotrophin signaling pathways for GBM cell survival under hypoxia.
Patient tumors exhibit both autophagic marker and TrkC/NT-3 expression enhancement
The overall results reported here were obtained with four different GBM cell lines and showed a cooperative effect of autophagy and TrkC signaling that ensured cell survival in response to hypoxia. In the last part of this work, we wanted to determine the autophagy and neutrophin characteristics of tumors from patients, in order to extend the data obtained in vitro. To this end, we checked BNIP3, LC3, TrkC and NT-3 expression by immunohistochemistry. The analysis was done on tumor sections from 20 patients with GBM compared with 5 cavernoma (used as a non-tumoral cerebral tissue control) ( Figure 5A ). A high BNIP3 expression level was found in both tissues, confirming the hypoxic character of GBM. The high value obtained in cavernoma was not surprising, due to the blood vessel malformation characteristic of this disease. However, it is noteworthy that BNIP3 expression is cytosolic in cavernoma, whereas it is mainly nuclear in GBM, which could explain in part the high degree of GBM malignity as previously described (34) . The hypoxic microenvironment could also probably explain the similar LC3 labeling we obtained in both pathologies. However, the expression pattern of TrkC and NT-3 was greatly different between GBM and cavernoma tissues ( Figure 5A ). Patients with GBM showed a high TrkC and NT-3 expression in comparison with cavernoma (respectively 96.93 ± 17.55 and 6.36 ± 2.18 for TrkC and 58.01 ± 7.13 and 6.74 ± 0.21 for NT-3, P < 0.001). These data highlight the importance of neurotrophic expression in GBM tumor and support the existence of a TrkC/NT-3 signaling loop that favors cell survival.
Being aware that cavernoma samples are not the best controls, we resolved to hunt the same markers in serial sections of GBM tumors, including tumoral and peri-tumoral tissues, ( Figure 5B ). We confirmed a very high expression of TrkC and nuclear BNIP3, overlaying the proliferation area as indicated by Ki67 staining. These labelings were especially localized in the tumoral cells since proliferating areas were only present in adult tumor brain whereas they were absent from normal tissue. A faint LC3 autophagy staining was also observed in this zone. Gradually as one moves away from the heart of the tumor, the different labelings became weaker. These data emphasize the specific high level of autophagy and TrkC expression in tumoral cells and corroborate the potential role of these signaling pathways in resistance to hypoxia and in GBM aggressiveness.
Discussion
Hypoxia constitutes a frequent stress encountered in solid tumors such as GBM. This feature is mainly based on the vasculature network inability to supply appropriate amounts of nutriment and oxygen (35) . Whereas this stress is lethal to most cells, tumor cells display adaptive solutions, which overcome these issues. Among them, autophagy takes place. This survival process, evolutionarily conserved and genetically controlled, is defined as an intracellular degradation system addressing cytoplasmic constituents to the lysosome (36, 37) . Thanks to its recycling function of unfolded or altered proteins and organelles, it contributes to cellular resistance against metabolic or oxidative environmental stress. In cancer cells, this process has been described as a double edge issue, acting either as a tumorpromoting factor or a tumor suppressor (14, 38) . Furthermore, depending on stress (and its level) and cellular types, autophagy also could lead to cell death. In a previous study, we reported that autophagic pathway activation in response to CoCl 2 (a hypoxia mimetic drug) induced death in neuroblastoma cell line harboring a mutated p53 (19) . In glioblastoma, it has been previously shown that hypoxia could induce an autophagy-dependent tumoral cell survival (12) . The present study corroborated Histogram quantification was obtained after normalization relative to siControl. Error bars represent mean deviation (mean of 3 independent experiments, n.s.: not significant; ***P < 0.001). (D) PARP cleavage was visualized by western blot in the same conditions and quantified (right panel; n.s.: not significant; **P < 0.01; ***P < 0.001). data in two different GBM cell lines: we evidenced a functional autophagic process as shown with LC3II enhancement and p62 decrease under oxygen deprivation. This accumulation is particularly significant in the presence of the lysosome inhibitor, chloroquine (CQ), supporting the efficient recycling function of the process.
GBM are especially apoptosis-resistant tumors that constitute a hallmark of cancer (39) , probably due to their enhanced propensity to develop autophagy. Yet, in several models, including glioma (40) , it appears that apoptosis and autophagy are mutually exclusive processes (15) . That is why we inhibited the survival pathway either pharmacologically or by using siRNA against transcripts of autophagy-involved proteins. In both cases, the mitochondrial metabolic activity (succinate dehydrogenase, assessed by XTT assay) was largely reduced whilst no substantial cell loss could be evidenced, probably supporting an entrance into a quiescent state rather than a cell death process. We failed to induce an apoptotic response as indicated by the absence of PARP cleavage in the studied cell lines. Even if we cannot exclude another cell death pathway, these results indicated that autophagy inhibition is not enough to restore an apoptotic death of hypoxic GBM cells, as already published (41) .
Neurotrophins and their receptors constitute growth factor signaling pathways initially involved in cell physiology of neural cells (42) and present in numerous cell types. Although recent studies highlight their roles in cancer biology and progression (43, 44) , the precise function of Trk receptor expression in GBM is not fully understood. We hypothesized that this growth factor receptor family could be involved in the resistance of glioblastoma cells to hypoxia, in complement of autophagy activation. Indeed, hypoxia-cultured GBM cells exhibited an enhancement of both TrkC and NT-3 expressions when compared to normoxia. This increase did not involve either TrkB/BDNF, whose level remained unchanged, or TrkA/NGF, absent from these cell lines. Hypoxia induced overexpression of TrkC and a downstream potentiation of p38MAPK, a well-known stress-associated pathway. This enhancement was even more prominent when autophagy was inhibited, corroborating a pro-tumoral function of this kinase (45) . This highlights the powerful role of TrkC/NT-3 in GBM cell survival with a compensatory effect of autophagy defect. Links between p38MAPK and the autophagic process have been previously studied in several cancer models (46) (47) (48) . It is well known that p38MAPK plays an important role in the regulation of apoptosis, cell cycle arrest, growth inhibition and differentiation. Previous studies, dealing with the molecular process of this interaction, demonstrated that p38 MAPK can negatively regulate both starvation and senescence-induced autophagy through a negative regulation of the mAtg9/p38IP complex formation (48, 49) . These authors argued on reduced amino-acid levels, driving inactivation of p38, in order to provide metabolic precursors by means of autophagy, which was not the case in hypoxia. However, other studies reported a positive role (50, 51) . Such contradictory works are of little help in determining the exact role of this MAP kinase in the regulation of autophagy, which seems to be both a positive or negative regulator (47) . These conflicting results may suggest that the role of p38α in autophagy is dependent on the cell type or the stimulus responsible for its activation. Our results indicate that both processes may exist within the same GBM cell type and promote survival in response to hypoxic stress. However, further analysis is needed to elucidate the possible links between these two pathways in this tumor model.
Finally the relevance of TrkC/NT-3 pathway was also supported by ex vivo observations, established on 20 patients. Indeed, strong expressions of both neurotrophin and its receptor were found specifically in tissues from GBM patients. Furthermore, within the same tumor, we observed a differential expression level, low in the infiltrated parenchyma and high in the tumoral area. Under hypoxic stress, the simultaneous expression of hypoxic, autophagic and neurotrophic markers (respectively BNIP3, LC3 punctiform staining and TrkC) suggests a cooperative effect, allowing cell proliferation (supported by Ki67 staining) contributing to GBM aggressiveness. These data agree in part with Lawn et al (43) who reported, in tumor samples, a strong expression of TrkB and TrkC as well as BDNF and NT-3, which is particularly significant in relation to the survival of brain-tumor initiating cells.
Finally, in order to try to kill tumor cells, inhibition of both survival pathways was performed and succeeded to induce an apoptotic cell death as indicated by PARP cleavage and cell loss. Although autophagic inhibition is often sufficient to restore apoptotic cell death in several models (14, 19, 52) , GBM are strongly hypoxia-resistant tumors and combined treatments are necessary to inhibit proliferation, as previously reported (41, 53) . In an earlier study, Hansen et al. (25) targeted neurotrophin pathway to induce an autophagic cell death. However, this was dependent on overexpression of TrkA, which is absent in U87MG and M059K cell lines. Bassili et al. also described an incidence of neutrophin expression and autocrine loop in brain tumors cell fate (54) , potentially contributing to cell stress resistance. For these last years, Trk inhibitors became available (55); so, a promising future GBM therapy could consist in a combination of CQ and Trk inhibition.
In conclusion (Figure 6 ), these data support that both autophagy and neurotrophin pathway (i.e. TrkC/NT-3) cooperate to induce a strong hypoxia resistance of GBM cells, that probably contribute to aggressiveness. The dual inhibition of both signaling pathways is necessary to induce cell death, which suggests that combined treatment is mandatory.
Supplementary Material
Supplementary data are available at Carcinogenesis online.
